Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006, 118 (3): 978–984
    Hallander, H. O., Nilsson, L., Gustafsson, L.: Is adolescent pertussis vaccination preferable to natural booster infections? Expert Rev Clin Pharmacol 2011, 4 (6): 705–711
    Herzig, P., Harmann, C., Fischer, D., Weil, J., von Kries, R., Schroten, H., Wirsing von König, C. H.: Pertussis complications in Germany – 3 years of hospital-based surveillance during the introduction of acellular vaccines. Infection 1998, 26 (4): 227–231
    Hofstetter, H. H., Shive, C. L., Forsthuber, T. G.: Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund’s adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J Immunol 2002, 169 (1): 117–125
    HRSA (Health Resources and Services Administration): Vaccine Injury Table 22.7.2011. http:// www.hrsa.gov/vaccinecompensation/vaccinetable.html (Zugriff 2. 12. 2011)
    Hviid, A., Stellfeld, M., Wohlfahrt, J., Andersen, P. H., Melbye, M.: The impact of pre-school booster vaccination of 4–6-year-old children on pertussis in 0–1-year-old children. Vaccine 2006, 24 (9): 1401–1407
    Kemmeren, J. M., Timmer, S. S., van der Maas, N. A., de Melker, H. E.: Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children. Vaccine 2011, 29 (26): 4373–4377
    Knuf, M., Zepp, C., Habermehl, P., Faser, E., Wirsing von König, C. H., et al.: Pertussisauffrischung bei ungeimpften Jugendlichen – eine Impfung oder 3 Impfungen? Pädiat Prax 2006, 67: 7–12
    Lam, C., Octavia, S., Bahrame, Z., Sintchenko, V., et al.: Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis. Infect Genet Evol 2012, 12 (2): 492–495
    Lugauer, S., Heininger, K., Stehr, J., Cherry, D.: Untersuchung zur Schutzdauer nach Pertussis-Grundimmunisierung mit Ganzkeim- bzw. azellulärer Vakzine (Abstract). Kinderärztl Praxis 1999, Abstracts zur 7. Jahrestagung der DGPI : 442
    Mascart, F., Hainaut, M., Peltier, A., Verscheure, V., et al.: Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 2007, 25 (2): 391–398
    McIntosh, A. M., McMahon, J., Dibbens, L. M., Iona, X., et al.: Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study. Lancet Neurol 2010, 9 (6): 592–598
    MMWR (Morbidity and Mortality Weekly Report): Pertussis – United States 1997–2000. MMWR 2002, 51 (4): 73–76
    Montella, M., Maso, L. D., Crispo, A., Talaminim, R., et al.: Do childhood diseases affect NHL and HL risk? A case-control study from northern and southern Italy. Leuk Res 2006, 30 (8): 917–922
    Mooi, F. R.: Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 2010, 10 (1): 36–49
    MSU (Mississippi State University) 2006: Study targets safer vaccine for often-fatal whooping cough. http:// www.msstate.edu/web/media/detail.php?id=3652 (Zugriff 2. 12. 2011)
    Murthy, J. M.: Acute disseminated encephalomyelitis. Neurol India 2002, 50: 238–243
    Nilsson, L., Lepp, T., von Segebaden, K., Hallander, H.: Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance. Vaccine 2011, 30 (21): 3239–3247
    Octavia, S., Sintchenko, V., Gilbert, G. L., Lawrence, A.: Newly Emerging Clones of Bordetella pertussis Carrying prn2 and ptxP3 Alleles Implicated in Australian Pertussis Epidemic in 2008–2010. J Infect Dis 2012, 205 (8): 1220–1224
    Popescu, R.: Whooping cough experts rely on vaccine companies for money, ethical dilemmas abound. Investigative New Source 10.12.2010. http:// www.inewsource.org/2010/12/14/blurred-lines-of-influence (Zugriff 30. 11. 2011)
    RKI (Robert-Koch-Institut): Merkblatt für Ärzte – Empfehlungen für die Wiederzulassung in Schulen und sonstigen Gemeinschaftseinrichtungen. 1999. http:// www.rki.de/ DE /Content/Infekt/EpidBull/Merkblaetter/Wiederzulassung/Mbl__Wiederzulassung__schule.html (Zugriff 18. 2. 2012)
    RKI (Robert-Koch-Institut): RKI -Ratgeber für Ärzte – Pertussis (Keuchhusten). Aktualisierte Fassung, August 2010. http://edoc.rki.de/series/rki-ratgeber-fuer-arzte/2010/ PDF /pertussis-%28keuchhusten%29.pdf (Zugriff